Monte Rosa Therapeutics (GLUE) Return on Sales (2024 - 2025)
Monte Rosa Therapeutics' Return on Sales history spans 2 years, with the latest figure at 16.59% for Q4 2025.
- For Q4 2025, Return on Sales fell 1763.0% year-over-year to 16.59%; the TTM value through Dec 2025 reached 0.31%, changed 0.0%, while the annual FY2025 figure was 0.31%, 0.0% changed from the prior year.
- Return on Sales reached 16.59% in Q4 2025 per GLUE's latest filing, down from 2.12% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 1.04% in Q4 2024 to a low of 30.06% in Q1 2024.